Chirurgie à visée curative des métastases péritonéales

Translated title of the contribution: Curative surgery for peritoneal metastases

D. Elias, D. Goéré, C. Honoré, D. Malka, V. Boige, P. Burtin, M. Ducreux

Research output: Contribution to journalArticlepeer-review


The complete resection of the peritoneal metastases (PM), followed with HIPEC (hyperthermic intraperitoneal chemotherapy, whose precise therapeutic impact is not yet well-known), allows to obtain numerous cures in eligible patients. This is currently the gold-standard treatment when it is possible. Its survival results are strictly similar to those obtained with hepatectomy for liver metastases (LM). The survival rate of the patients with early PM is particularly high, far superior to those of any hepatectomized patient. The main progress will be to early-operate these patients, or to propose a prophylactic approach to those presenting a high-risk to develop PM. The concept of second-look surgery + HIPEC is the logical extension of this combined approach. In contrast, a non-complete cytoreductive surgery and a large peritoneal extension are contraindications to use this approach.

Translated title of the contributionCurative surgery for peritoneal metastases
Original languageFrench
Pages (from-to)543-548
Number of pages6
Issue number11-12
StatePublished - 30 Dec 2014
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2014, Springer-Verlag France.


  • Colorectal cancer
  • Cytoreductive surgery
  • Peritoneal metastases


Dive into the research topics of 'Curative surgery for peritoneal metastases'. Together they form a unique fingerprint.

Cite this